Technology News

Cell Signaling Inks Protein Research Deal

Thursday, December 07, 2006 6:00:00 AM PDT | VentureDeal Staff

DANVERS, MA --  Cell Signaling Technology, Inc. announced that it had signed an agreement with Bristol-Myers Squibb to perform a phosphoproteomic research for the drug giant.

While terms of the agreement were not disclosed, the company indicated that the research to be done included its PhosphoScan technology to provide Bristol-Myers with cellular phospho-profiles of a small molecule kinase inhibitor.

Cell Signaling Technology has a large product line of phospho-related testing systems and supplies.

Email Page  Email Page | Print Page Print Page

Free Trial

Want unlimited access to the complete database with thousands of technology companies, VCs and transactions for only $25 per month?

Start your Free 14 Day Trial now – no obligation or credit card required.

Free 14 day trial. No Obligation. Click to Register.
Venturedeal Twitter Venturedeal Facebook Venturedeal Linkedin

PCI - Level1